224 related articles for article (PubMed ID: 30607517)
1. Managing fibromyalgia syndrome in pregnancy no bridges between USA and EU.
Gentile S; Fusco ML
Arch Womens Ment Health; 2019 Dec; 22(6):711-721. PubMed ID: 30607517
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Amitriptyline and US Food and Drug Administration-Approved Treatments for Fibromyalgia: A Systematic Review and Network Meta-analysis.
Farag HM; Yunusa I; Goswami H; Sultan I; Doucette JA; Eguale T
JAMA Netw Open; 2022 May; 5(5):e2212939. PubMed ID: 35587348
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy and tolerability of duloxetine, pregabalin, and milnacipran for the treatment of fibromyalgia: a Bayesian network meta-analysis of randomized controlled trials.
Lee YH; Song GG
Rheumatol Int; 2016 May; 36(5):663-72. PubMed ID: 27000046
[TBL] [Abstract][Full Text] [Related]
4. Healthcare Costs and Medication Adherence Among Patients with Fibromyalgia: Combination Medication vs. Duloxetine, Milnacipran, Venlafaxine, and Pregabalin Initiators.
Marlow NM; Simpson KN; Vaughn IA; Jo A; Zoller JS; Short EB
Pain Pract; 2018 Feb; 18(2):154-169. PubMed ID: 28419725
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Real-World Dosing Patterns for the 3 FDA-Approved Medications in the Treatment of Fibromyalgia.
White C; Kwong WJ; Armstrong H; Behling M; Niemira J; Lang K
Am Health Drug Benefits; 2018 Sep; 11(6):293-301. PubMed ID: 30464796
[TBL] [Abstract][Full Text] [Related]
6. Serotonin and Norepinephrine Reuptake Inhibitors.
Shelton RC
Handb Exp Pharmacol; 2019; 250():145-180. PubMed ID: 30838456
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy of fibromyalgia.
Traynor LM; Thiessen CN; Traynor AP
Am J Health Syst Pharm; 2011 Jul; 68(14):1307-19. PubMed ID: 21719591
[TBL] [Abstract][Full Text] [Related]
8. Focus on pain mechanisms and pharmacotherapy in the treatment of fibromyalgia syndrome.
Malemud CJ
Clin Exp Rheumatol; 2009; 27(5 Suppl 56):S86-91. PubMed ID: 20074446
[TBL] [Abstract][Full Text] [Related]
9. Milnacipran: serotonin-noradrenaline reuptake inhibitor approved for fibromyalgia may be a useful antidepressant.
Keks NA; Hope J; Keogh S; Copolov DL
Australas Psychiatry; 2018 Oct; 26(5):537-540. PubMed ID: 30198305
[TBL] [Abstract][Full Text] [Related]
10. Analgesic Medication in Fibromyalgia Patients: A Cross-Sectional Study.
Aster HC; Evdokimov D; Braun A; Üçeyler N; Sommer C
Pain Res Manag; 2022; 2022():1217717. PubMed ID: 36247103
[TBL] [Abstract][Full Text] [Related]
11. Combination of pregabalin with duloxetine for fibromyalgia: a randomized controlled trial.
Gilron I; Chaparro LE; Tu D; Holden RR; Milev R; Towheed T; DuMerton-Shore D; Walker S
Pain; 2016 Jul; 157(7):1532-40. PubMed ID: 26982602
[TBL] [Abstract][Full Text] [Related]
12. Comparing duloxetine and pregabalin for treatment of pain and depression in women with fibromyalgia: an open-label randomized clinical trial.
Bidari A; Moazen-Zadeh E; Ghavidel-Parsa B; Rahmani S; Hosseini S; Hassankhani A
Daru; 2019 Jun; 27(1):149-158. PubMed ID: 30877484
[TBL] [Abstract][Full Text] [Related]
13. Patterns of health care utilization related to initiation of amitriptyline, duloxetine, gabapentin, or pregabalin in fibromyalgia.
Kim SC; Landon JE; Lee YC
Arthritis Res Ther; 2015 Jan; 17(1):18. PubMed ID: 25627453
[TBL] [Abstract][Full Text] [Related]
14. The effect of fibromyalgia treatment on tinnitus.
Cil ÖÇ; Zateri C; Güçlü O; Oymak S; Tezcan E
Am J Otolaryngol; 2020; 41(3):102390. PubMed ID: 31926598
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological management of fibromyalgia: a Bayesian network meta-analysis.
Migliorini F; Maffulli N; Eschweiler J; Knobe M; Tingart M; Colarossi G
Expert Rev Clin Pharmacol; 2022 Feb; 15(2):205-214. PubMed ID: 35184627
[TBL] [Abstract][Full Text] [Related]
16. Milnacipran for the management of fibromyalgia syndrome.
Ormseth MJ; Eyler AE; Hammonds CL; Boomershine CS
J Pain Res; 2010 Mar; 3():15-24. PubMed ID: 21197306
[TBL] [Abstract][Full Text] [Related]
17. Fibromyalgia: Diagnosis and Management.
Winslow BT; Vandal C; Dang L
Am Fam Physician; 2023 Feb; 107(2):137-144. PubMed ID: 36791450
[TBL] [Abstract][Full Text] [Related]
18. Chronic Pain Syndromes: Fibromyalgia.
Flynn D
FP Essent; 2023 Oct; 533():7-15. PubMed ID: 37812528
[TBL] [Abstract][Full Text] [Related]
19. A probable case of movement disorder (Tardive dyskinesia) due to duloxetine treatment.
Yılmaz R; Üstün D; Tuncer Uzun S; Reisli R; Türk Ş
Agri; 2018 Oct; 30(4):199-201. PubMed ID: 30403275
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
